Signalling defects in anti-tumour T cells.
The immune response to cancer has been long recognised, including both innate and adaptive responses, showing that the immune system can recognise protein products of genetic and epigenetic changes in transformed cells. The accumulation of antigen-specific T cells within the tumour, the draining lymph node, and the circulation, either in newly diagnosed patients or resultant […]
read more